Prevalence of Co-morbidities and severity of COPD

Salvatore Battaglia, Marco Basile, Nicola Scichilone, Vincenzo Bellia

Research output: Contribution to journalArticle

Abstract

We aimed at exploring whether the prevalence of co-morbidities of chronic obstructive pulmonary disease (COPD) increases with COPD severity. Analysis of medical records of outpatients with established diagnosis of COPD was retrospectively performed. The lower limit of normality (LLN) for FEV1/FVC was applied to establish the occurrence of airway obstruction in the elderly population. The prevalence of co-morbidities was calculated, and the proportion of patients with each co-morbidity along with GOLD stages was analysed by chi-square for trend. A total of 326 (M/F: 256/70) consecutive outpatients with COPD (stage GOLD I to IV), aging 71.8 ± 9.2 years, were included in the analysis. The most frequent co-morbidities in the entire sample were systemic hypertension (64.7%), diabetes (28.5%), coronary artery disease (19.9%), arrhythmias (16.6%) and congestive heart failure (13.8%). Underweight patients were 8.0% of the sample while obese patients were 22.4%. None of the analyzed co-morbidities showed a trend towards increasing prevalence with COPD severity, except for nutritional problems. The current findings suggest that the occurrence and prevalence of co-morbidities is independent from the COPD severity, and encourage to assess co-morbidities even in the early stages of the COPD.

Original languageEnglish (US)
Pages (from-to)390-394
Number of pages5
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume12
Issue number4
DOIs
StatePublished - Jul 4 2015
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Morbidity
Outpatients
Thinness
Airway Obstruction
Medical Records
Cardiac Arrhythmias
Coronary Artery Disease
Heart Failure
Hypertension
Population

Keywords

  • co-morbidities
  • COPD
  • epidemiology
  • prevalence
  • systemic effects

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Prevalence of Co-morbidities and severity of COPD. / Battaglia, Salvatore; Basile, Marco; Scichilone, Nicola; Bellia, Vincenzo.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 12, No. 4, 04.07.2015, p. 390-394.

Research output: Contribution to journalArticle

Battaglia, Salvatore ; Basile, Marco ; Scichilone, Nicola ; Bellia, Vincenzo. / Prevalence of Co-morbidities and severity of COPD. In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2015 ; Vol. 12, No. 4. pp. 390-394.
@article{d8889ca4236542d6b0dfca08a1338b36,
title = "Prevalence of Co-morbidities and severity of COPD",
abstract = "We aimed at exploring whether the prevalence of co-morbidities of chronic obstructive pulmonary disease (COPD) increases with COPD severity. Analysis of medical records of outpatients with established diagnosis of COPD was retrospectively performed. The lower limit of normality (LLN) for FEV1/FVC was applied to establish the occurrence of airway obstruction in the elderly population. The prevalence of co-morbidities was calculated, and the proportion of patients with each co-morbidity along with GOLD stages was analysed by chi-square for trend. A total of 326 (M/F: 256/70) consecutive outpatients with COPD (stage GOLD I to IV), aging 71.8 ± 9.2 years, were included in the analysis. The most frequent co-morbidities in the entire sample were systemic hypertension (64.7{\%}), diabetes (28.5{\%}), coronary artery disease (19.9{\%}), arrhythmias (16.6{\%}) and congestive heart failure (13.8{\%}). Underweight patients were 8.0{\%} of the sample while obese patients were 22.4{\%}. None of the analyzed co-morbidities showed a trend towards increasing prevalence with COPD severity, except for nutritional problems. The current findings suggest that the occurrence and prevalence of co-morbidities is independent from the COPD severity, and encourage to assess co-morbidities even in the early stages of the COPD.",
keywords = "co-morbidities, COPD, epidemiology, prevalence, systemic effects",
author = "Salvatore Battaglia and Marco Basile and Nicola Scichilone and Vincenzo Bellia",
year = "2015",
month = "7",
day = "4",
doi = "10.3109/15412555.2014.974734",
language = "English (US)",
volume = "12",
pages = "390--394",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Prevalence of Co-morbidities and severity of COPD

AU - Battaglia, Salvatore

AU - Basile, Marco

AU - Scichilone, Nicola

AU - Bellia, Vincenzo

PY - 2015/7/4

Y1 - 2015/7/4

N2 - We aimed at exploring whether the prevalence of co-morbidities of chronic obstructive pulmonary disease (COPD) increases with COPD severity. Analysis of medical records of outpatients with established diagnosis of COPD was retrospectively performed. The lower limit of normality (LLN) for FEV1/FVC was applied to establish the occurrence of airway obstruction in the elderly population. The prevalence of co-morbidities was calculated, and the proportion of patients with each co-morbidity along with GOLD stages was analysed by chi-square for trend. A total of 326 (M/F: 256/70) consecutive outpatients with COPD (stage GOLD I to IV), aging 71.8 ± 9.2 years, were included in the analysis. The most frequent co-morbidities in the entire sample were systemic hypertension (64.7%), diabetes (28.5%), coronary artery disease (19.9%), arrhythmias (16.6%) and congestive heart failure (13.8%). Underweight patients were 8.0% of the sample while obese patients were 22.4%. None of the analyzed co-morbidities showed a trend towards increasing prevalence with COPD severity, except for nutritional problems. The current findings suggest that the occurrence and prevalence of co-morbidities is independent from the COPD severity, and encourage to assess co-morbidities even in the early stages of the COPD.

AB - We aimed at exploring whether the prevalence of co-morbidities of chronic obstructive pulmonary disease (COPD) increases with COPD severity. Analysis of medical records of outpatients with established diagnosis of COPD was retrospectively performed. The lower limit of normality (LLN) for FEV1/FVC was applied to establish the occurrence of airway obstruction in the elderly population. The prevalence of co-morbidities was calculated, and the proportion of patients with each co-morbidity along with GOLD stages was analysed by chi-square for trend. A total of 326 (M/F: 256/70) consecutive outpatients with COPD (stage GOLD I to IV), aging 71.8 ± 9.2 years, were included in the analysis. The most frequent co-morbidities in the entire sample were systemic hypertension (64.7%), diabetes (28.5%), coronary artery disease (19.9%), arrhythmias (16.6%) and congestive heart failure (13.8%). Underweight patients were 8.0% of the sample while obese patients were 22.4%. None of the analyzed co-morbidities showed a trend towards increasing prevalence with COPD severity, except for nutritional problems. The current findings suggest that the occurrence and prevalence of co-morbidities is independent from the COPD severity, and encourage to assess co-morbidities even in the early stages of the COPD.

KW - co-morbidities

KW - COPD

KW - epidemiology

KW - prevalence

KW - systemic effects

UR - http://www.scopus.com/inward/record.url?scp=84939449516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939449516&partnerID=8YFLogxK

U2 - 10.3109/15412555.2014.974734

DO - 10.3109/15412555.2014.974734

M3 - Article

VL - 12

SP - 390

EP - 394

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 4

ER -